• Follicle Stimulating Hormone (FSH)
  • C9orf72 Hexanucleotide Repeat, Molecular Analysis
  • Chlordiazepoxide, Urine
  • Chlorpheniramine, Urine
  • Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
  • Solute Carrier Family 22 (SLC22A5) Gene Mutation Analysis
  • Heparin-PF4 Antibody (HIT)
  • Bordetella pertussis and Bordetella parapertussis, Molecular
  • Lead, Random, Urine
  • Steroid Sulfatase Gene, Xp22.3 Deletion, FISH
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
Medical Test

Reference Ranges
Access to Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS) is restricted.